Literature DB >> 24575006

Malignant melanoma with probable smooth muscle differentiation.

Aya Morimoto1, Jun Asai1, Yusuke Wakabayashi1, Satoshi Komori1, Keiji Hanada1, Hideya Takenaka1, Eiichi Konishi2, Norito Katoh1.   

Abstract

Malignant melanomas occasionally exhibit various divergent differentiation types. Of these, smooth muscle differentiation is extremely rare; only 1 case has been reported in the literature until recently. We report an extremely rare case of malignant melanoma with smooth muscle differentiation, which appeared as an amelanotic reddish nodule on the left toe.

Entities:  

Keywords:  Divergent differentiation; Malignant melanoma; Smooth muscle differentiation

Year:  2014        PMID: 24575006      PMCID: PMC3934611          DOI: 10.1159/000358375

Source DB:  PubMed          Journal:  Case Rep Dermatol        ISSN: 1662-6567


Introduction

Malignant melanomas occasionally exhibit various divergent differentiation types such as fibroblastic/myofibroblastic, schwannian and perineurial, smooth muscle, rhabdomyosarcomatous, osteocartilaginous, ganglionic and ganglioneuroblastic, neuroendocrine, and probable epithelial types [1, 2]. Of these, smooth muscle differentiation is extremely rare; only 1 case has been reported in the literature until recently [3]. We herein report an extremely rare case of malignant melanoma with smooth muscle differentiation, which appeared as an amelanotic reddish nodule on the left toe.

Case Presentation

A 63-year-old woman presented with an ulcerated reddish nodule on the left toe (fig. 1a). No pigmentation was observed in the lesion. The patient had no other pigmented lesion, which was suspected as malignant melanoma. Leiomyosarcoma was highly suspected based on an incisional biopsy performed at another hospital; thus, the patient was referred to our institution. Subsequently, the left toe was amputated. Histopathologically, the neoplasm occupied the entire dermis (fig. 1b) and was composed of pleomorphic spindle cells with eosinophilic cytoplasm, blunt-ended nuclei, and perinuclear vacuoles (fig. 1c). Mitosis was frequently observed (47 mitosis/10 high-power fields). Alfa smooth muscle actin (α-SMA; fig. 1d) and desmin (fig. 1e) were diffusely positive. S-100 was focally positive (fig. 1f). At that time, these findings suggested a diagnosis of cutaneous leiomyosarcoma. Seven months after the amputation, the patient presented with left groin lymph node swelling. Analysis of the excised lymph node showed replacement of lymph node tissue with a cytologically uniform eosinophilic spindle cell neoplasm (fig. 1g). Immunohistochemically, the spindle cells were diffusely positive for S-100 (fig. 1h) and α-SMA (fig. 1i). Staining for microphthalmia transcription factor (MiTF; fig. 1j) and HMB45 (fig. 1k) was focally positive. Melan-A-positive cells were scarcely observed (fig. 1l). Since whole tissues were embedded in paraffin block, electron microscopic analysis could not be performed. Finally, we made the diagnosis of spindle cell melanoma with probable smooth muscle differentiation. Two years after lymph node dissection followed by 5 courses of chemotherapy (dacarbazine, nimustine hydrochloride, vincristine sulfate, and interferon beta), no local recurrence or distant metastasis was observed.
Fig. 1

a An ulcerated reddish nodule on the left toe. b The neoplasm occupied the entire dermis (hematoxylin-eosin stain). c–f Histopathological findings of the neoplasm in the left toe. Pleomorphic spindle cells with eosinophilic cytoplasm, blunt-ended nuclei, and perinuclear vacuoles (c hematoxylin-eosin stain). Cells were diffusely positive for α-SMA (d) and desmin (e). Cells were focally positive for S-100 (f). g–l Histopathological findings of the lymph node. g Cytologically uniform eosinophilic spindle cell neoplasm showed remarkable neural-like cytomorphology (hematoxylin-eosin staining). Cells were diffusely positive for S-100 (h) and α-SMA (i). Cells were focally positive for MiTF (j) and HMB45 (k). Only a small number of cells were positive for melan-A (l) [original magnifications: ×12.5 (b); ×200 (d–i); ×400 (c, j–l)].

Discussion

Malignant melanomas occasionally exhibit divergent differentiation, thus resulting in difficulties in diagnosis. In this case, smooth muscle differentiation was detected by immunostaining for α-SMA and desmin. Desmin is the intermediate filament protein associated with both smooth and skeletal muscle differentiation; therefore, desmin is the most sensitive marker for this type of differentiation. Malignant melanomas rarely show positivity for desmin, which generally represents rhabdomyoblastic differentiation [1, 4]. In contrast, smooth muscle differentiation of a melanoma can be identified by α-SMA positivity in addition to desmin positivity [3]. In the present case, immunohistological examination of the primary lesion showed negative staining for melanoma-specific markers such as HMB45 and melan-A. Thus, we misdiagnosed the lesion as a cutaneous leiomyosarcoma until immunohistochemical analysis of the metastatic lesion showed positive staining for MiTF and HMB45. Since cutaneous leiomyosarcomas clinically behave in benign fashion in general [5], careful examination is essential to distinguish them from malignant melanomas. In conclusion, we report a rare, but highly instructive case of malignant melanoma with smooth probable muscle differentiation. Malignant melanoma should always be considered as a differential diagnosis for such lesions, since various divergent differentiation types may be observed in melanomas.

Disclosure Statement

The authors report that they have no conflicts of interest.
  5 in total

1.  Rhabdomyoblastic differentiation in malignant melanoma in adults: report of 2 cases.

Authors:  Deepa Gharpuray-Pandit; John Coyne; Brian Eyden; S Sankar Banerjee
Journal:  Int J Surg Pathol       Date:  2007-01       Impact factor: 1.271

Review 2.  Morphological and immunophenotypic variations in malignant melanoma.

Authors:  S S Banerjee; M Harris
Journal:  Histopathology       Date:  2000-05       Impact factor: 5.087

3.  Intradermal and subcutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 41 cases.

Authors:  M L Jensen; O M Jensen; W Michalski; O S Nielsen; J Keller
Journal:  J Cutan Pathol       Date:  1996-10       Impact factor: 1.587

4.  Malignant melanoma showing smooth muscle differentiation.

Authors:  S S Banerjee; P W Bishop; C M Nicholson; B P Eyden
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

Review 5.  Divergent differentiation in malignant melanomas: a review.

Authors:  S S Banerjee; B Eyden
Journal:  Histopathology       Date:  2007-09-07       Impact factor: 5.087

  5 in total
  3 in total

1.  Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity.

Authors:  Haider A Mejbel; Sri Krishna C Arudra; Dinesh Pradhan; Carlos A Torres-Cabala; Priyadharsini Nagarajan; Michael T Tetzlaff; Jonathan L Curry; Doina Ivan; Dzifa Y Duose; Raja Luthra; Victor G Prieto; Leomar Y Ballester; Phyu P Aung
Journal:  Cancers (Basel)       Date:  2019-11-02       Impact factor: 6.639

Review 2.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08

Review 3.  Unusual Clinical Presentations of Malignant Melanoma: A Review of Clinical and Histologic Features with Special Emphasis on Dermatoscopic Findings.

Authors:  Raúl Cabrera; Francisca Recule
Journal:  Am J Clin Dermatol       Date:  2018-11       Impact factor: 7.403

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.